language_icon
EN
HI

Syncom Formulations (India) Share price

SYNCOMF

14.26

0.15 (1.06%)
NSE
BSE
Last updated on 21 May, 2026 | 15:31 IST
Today's High

14.65

Today's Low

14.11

52 Week Low

10.21

52 Week High

23.49

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Syncom Formulations (India) Chart

Syncom Formulations (India) Share Key Metrics

Volume
15.32 L
Market Cap
1340.44 CR
LTQ@LTP
1000@14.26
ATP
14.32
Var Margin
20.95 %
Circuit Range
11.29-16.93
Delivery %
44.6 %
Value
2.19 CR
ASM/GSM
No
Market Lot
1

Summary

Syncom Formulations (India) share price is ₹14.26 as of 22 May, 2026. The stock Syncom Formulations (India) intraday movement has stayed between ₹14.11 and ₹14.65, while on a 52-week basis,Syncom Formulations (India) price 52 week high is ₹23.49 & its 52 week low is ₹10.21.
In terms of trading activity, Syncom Formulations (India) has recorded a volume of 1532153 shares, The Syncom Formulations (India) has a market cap of ₹940000000 CR. The stock’s Average Traded Price (ATP) stands at ₹14.32, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1000 @ ₹14.26.
Syncom Formulations (India) operates within a circuit range of ₹11.29 – ₹16.93, with a Value of ₹2.19 CR. The Delivery Percentage for the day is 44.6%. Additionally, Syncom Formulations (India) currently falls under the No framework, and trades with a market lot size of 1.

Syncom Formulations (India) Fundamentals

View More
P/E Ratio

19.25

P/B Ratio

3.34

Div. Yield

0

Sector P/E

71.81

Sector P/B

3.44

Sec. Div. Yield

0.55

Syncom Formulations (India) Resistance and Support

Pivot 14.13

Resistance

First Resistance

14.33

Second Resistance

14.54

Third Resistance

14.74

Support

First Support

13.92

Second Support

13.72

Third Support

13.51

Syncom Formulations (India) Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

50.57%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.21%

Domestic Institutional Investors

0%

Retail

49.21%

Others

0.01%

Total Promoters
MAR '26
50.57%

Syncom Formulations (India) Corporate Actions

DateAgenda
2026-05-22Audited Results
2026-02-12Quarterly Results
2025-11-12Quarterly Results
2025-05-19Audited Results
2025-02-10Quarterly Results & Others

Syncom Formulations (India) News

Syncom Formulations (India) Limited

Syncom Formulations Board is scheduled to meet on May 22, 2026, to consider and approve its audited financial results for the quarter and full financial year ended March 31, 2026. This meeting will also include a review of the audit report and financial statements.
May 13 2026 16:05:00

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations, 2015 Regarding Intimation Of Holding Board Meeting For Consideration And Approval Of The Standalone And Consolidated Audited Financial Results, As On 31St March, 2026

Syncom Formulations board meeting scheduled for May 22, 2026, at 3:00 P.M. to consider and approve standalone and consolidated audited financial results for the quarter and year ended March 31, 2026.
May 13 2026 16:05:00

Syncom Formulations (India) Limited

Syncom Formulations has successfully acquired a commercial property for Rs. 57.26 crore from HDFC Bank Ltd. This acquisition of the entire 7th Floor, Trade Star, Andheri-Kurla Road, Mumbai, is considered material by the company for operational expansion.
May 04 2026 18:05:00

Syncom Formulations India Ltd-$ - 524470 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Read With Master SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 Dated 30Th January, 2026.

Syncom Formulations completed the acquisition of a commercial property, the entire 7th Floor of Trade Star in Andheri, Mumbai. The property was acquired for a total consideration of Rs. 57.26 crore from HDFC Bank Ltd, enhancing the company's operational footprint.
May 04 2026 18:05:00
Read More

About Syncom Formulations (India)

NSE : 11992  
BSE : 524470  
ISIN : INE312C01025  

Syncom Formulations (India) Management

NamePosition
Vaishali AgrawalCompany Secretary & Compliance Officer
Vijay Shankarlal BankdaManaging Director
View More

Syncom Formulations (India) FAQs

The Buying Price of Syncom Formulations (India) share is 14.26 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Syncom Formulations (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Syncom Formulations (India), choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Syncom Formulations (India) shares is 19.25. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Syncom Formulations (India) shares is 3.34. Useful to assess the stock's value relative to its book value.

To assess Syncom Formulations (India)’s valuation compare Sector P/E, P/B which are 71.81 & 3.44 with sector averages, along with growth rates and financial metrics.

The Market Cap of Syncom Formulations (India) is 1340.44 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Syncom Formulations (India) share price is 23.49 & 10.21. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Syncom Formulations (India) belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost